Clinical Trials Browser

Phase 3 × INDUSTRY × selpercatinib × Clear all

NCT04211337 2026-03-19

LIBRETTO-531

Phase 3 Active not recruiting

291 enrolled 16 charts 1 FDA

Carcinoma, Medullary

NCT04819100 2026-03-04

LIBRETTO-432

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04194944 2025-10-21

LIBRETTO-431

Phase 3 Active not recruiting

261 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung